Please use this identifier to cite or link to this item:
|Title:||Cross-priming of CD8+ T cells by viral and tumor antigens is a robust phenomenon.|
|Authors:||Chen, Weisan;Masterman, Kelly-Anne;Basta, Sameh;Haeryfar, S M Mansour;Dimopoulos, Nektaria;Knowles, Barbara;Bennink, Jack R;Yewdell, Jonathan W|
|Affiliation:||T Cell Laboratory, Cancer Vaccine Unit, Ludwig Institute for Cancer Research, Austin & Repatriation Medical Centre, Heidelberg, Australia.|
|Citation:||European Journal of Immunology; 34(1): 194-9|
|Abstract:||"Cross-priming" refers to the activation of naive CD8+ T cells by antigen-presenting cells that have acquired nominal antigens from another cell. The biological relevance of cross-priming of CD8+ T cells has recently been challenged (Zinkernagel, R. M., Eur. J. Immunol. 2002. 32: 2385-2392), on the basis that responses are weak or poorly quantitated, and the determinants recognized are undefined. Here we show that cross-priming is a robust process that elicits vigorous primary responses to multiple peptides in two well-defined systems. Our findings support the relevance of cross-priming in CD8+ T cell responses to viruses and tumor cells, and demonstrate that cross-priming elicits CD8+ T cells to determinants generated by the endogenous processing pathway.|
|Internal ID Number:||14971045|
Antigens, Polyomavirus Transforming.immunology
Influenza A virus.immunology
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.